Thomas Kryza

Thomas Kryza has held various roles in the field of research and development. Thomas started their career as a Technician at Etablissement Français du Sang in 2010. Thomas then worked as a PhD Student at Centre d'Etude des Pathologies Respiratoires INSERM U1100 / EA 6305, where they were involved in studying the angiogenesis process associated with lung cancer. Thomas gained experience in cell culture, functional assays, biochemistry, molecular biology, and microscopy during this role. From 2013 to 2014, Thomas worked as a Research Fellow at Centre d'Étude des Pathologies Respiratoires (CEPR) INSERM UMR 1100 / EA 6305.

In 2014, Thomas worked as a Visiting Research Scientist at Jacobs University Bremen, where they gained international research experience. Thomas then joined the Australian Prostate Cancer Research Centre as a Project Officer and worked there until 2018. During this time, they focused on prostate cancer research.

Thomas then became a Project Officer at Mater Research from 2018 to 2021, where they worked on various research projects. Thomas then transitioned to the role of Research Project Manager at Mater from 2021 to 2022. In this role, they managed research projects and contributed to the advancement of scientific knowledge.

Currently, Thomas is working as a Preclinical Development Manager at AdvanCell Isotopes Pty Ltd. Thomas is responsible for overseeing preclinical development activities.

Throughout their career, Thomas has demonstrated a strong background in research and development with expertise in various techniques and methodologies. Their work experience spans across academic research institutions and industry settings, showcasing their versatility and adaptability in different work environments.

Thomas Kryza began their education at IUT de Lille 1 in 2004, where they earned a DUT Génie Biologie degree in Biotechnology. From 2004 to 2007, they pursued further studies at the University of Lille 1 Sciences and Technology, obtaining a license in Cellular Biology and Physiology. Thomas then went on to complete a Master recherche Biologie-Santé degree in Biotechnology from 2007 to 2009 at the same institution. Finally, from 2010 to 2013, Thomas studied at Université de Tours, earning a Doctorate in Biochemistry with a focus on Life and Health Sciences.